Pàgina inicial > Resultats de la cerca: Aguiar, Patrício
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 3 registres trobats en 0.03 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat : a modified Delphi study / Bichet, Daniel G. (University of Montréal, Canada) ; Hopkin, Robert J. (University of Cincinnati College of Medicine, United States) ; Aguiar, Patrício (Lisbon University) ; Allam, Sridhar R. (Texas Christian University, Fort Worth, United States) ; Chien, Yin-Hsiu (National Taiwan University College of Medicine, Taipei, Taiwan) ; Giugliani, Roberto (Postgraduate Program in Genetics and Molecular Biology (PPGBM) at Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil) ; Kallish, Staci (University of Pennsylvania, Philadelphia, United States) ; Kineen, Sabina (Patient Advocate, United States) ; Lidove, Olivier (French Network of Inherited Metabolic Disorders (G2m), France) ; Niu, Dau-Ming (National Yang Ming Chiao Tung University, Taipei, Taiwan) ; Olivotto, Iacopo (Meyer University Children's Hospital, Florence, Italy) ; Politei, Juan (Fundacion Para el Estudio de Enfermedades Neurometabolicas (FESEN), Buenos Aires, Argentina) ; Rakoski, Paul (Patient Advocate, United States) ; Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Tøndel, Camilla (University of Bergen, Norway) ; Hughes, Derralynn A. (Royal Free London NHS Foundation Trust and University College London, United Kingdom) ; Universitat Autònoma de Barcelona. Departament de Medicina
Fabry disease is a progressive disorder caused by deficiency of the α-galactosidase A enzyme (α-Gal A), leading to multisystemic organ damage with heterogenous clinical presentation. The addition of the oral chaperone therapy migalastat to the available treatment options for Fabry disease is not yet universally reflected in all treatment guidelines. [...]
2023 - 10.3389/fmed.2023.1220637
Frontiers in Medicine, Vol. 10 (september 2023)  
Registre complet - Creative Commons
2.
15 p, 1.1 MB Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease? / Hughes, Derralynn A. (University College London) ; Aguiar, Patrício (Lisbon University) ; Lidove, Olivier (Croix Saint Simon Hospital, Paris) ; Nicholls, Kathleen (University of Melbourne) ; Nowak, Albina (University Hospital Zurich (Suïssa)) ; Thomas, Mark (Cincinnati Children's Hospital Medical Center (CCHMC). Center for Fetal and Placental Research) ; Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Vujkovac, Bojan (General Hospital Slovenj Gradec) ; West, Michael L. (Dalhousie University) ; Feriozzi, Sandro (Belcolle Hospital) ; Universitat Autònoma de Barcelona
Variable disease progression confounds accurate prognosis in Fabry disease. Evidence supports the long-term benefit of early intervention with disease-specific therapy, but current guidelines recommend treatment initiation based on signs that may present too late to avoid irreversible organ damage. [...]
2022 - 10.1186/s13023-022-02181-4
Orphanet Journal of Rare Diseases, Vol. 17 (february 2022)  
Registre complet - Creative Commons
3.
12 p, 1.2 MB Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation : findings from the opinion-based PREDICT-FD modified Delphi consensus initiative / Hughes, Derralynn A. (University College London) ; Aguiar, Patrício (University of Lisbon) ; Deegan, Patrick B. (University of Cambridge) ; Ezgu, Fatih (Gazi University) ; Frustaci, Andrea (University of Rome La Sapienza) ; Lidove, Olivier (Croix Saint Simon Hospital) ; Linhart, Aleš (Charles University. Faculty of Medicine in Hradec Králové) ; Lubanda, Jean-Claude (Charles University. Faculty of Medicine in Hradec Králové) ; Moon, James C. (Barts Heart Centre) ; Nicholls, Kathleen (The University of Melbourne) ; Niu, Dau-Ming (National Yang-Ming University) ; Nowak, Albina (University Hospital Zurich (Suïssa)) ; Ramaswami, Uma (Royal Free Hospital) ; Reisin, Ricardo (British Hospital of Buenos Aires) ; Rozenfeld, Paula (Instituto de Estudios Inmunológicos y Fisiopatológicos, UNLP - CONICET, La Plata, Argentina) ; Schiffmann, Raphael (Baylor Research Institute) ; Svarstad, Einar (Haukeland University Hospital (Bergen, Noruega)) ; Thomas, Mark (Cincinnati Children's Hospital Medical Center) ; Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Vujkovac, Bojan (General Hospital Slovenj Gradec) ; Warnock, David G. (University of Alabama at Birmingham) ; West, Michael L. (Dalhousie University) ; Johnson, Jack (Fabry International Network) ; Rolfe, Mark J. (Oxford Pharmagenesis) ; Feriozzi, Sandro (Belcolle Hospital) ; Universitat Autònoma de Barcelona
The PRoposing Early Disease Indicators for Clinical Tracking in Fabry Disease (PREDICT-FD) initiative aimed to reach consensus among a panel of global experts on early indicators of disease progression that may justify FD-specific treatment initiation. [...]
2020 - 10.1136/bmjopen-2019-035182
BMJ open, Vol. 10 (october 2020)  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
16 Aguiar, Pablo
5 Aguiar, Pablo,
3 Aguiar, Patricio
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem